215 related articles for article (PubMed ID: 18975117)
1. In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues.
Thomas R; Chen J; Roudier MM; Vessella RL; Lantry LE; Nunn AD
Clin Exp Metastasis; 2009; 26(2):105-19. PubMed ID: 18975117
[TBL] [Abstract][Full Text] [Related]
2. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
Lantry LE; Cappelletti E; Maddalena ME; Fox JS; Feng W; Chen J; Thomas R; Eaton SM; Bogdan NJ; Arunachalam T; Reubi JC; Raju N; Metcalfe EC; Lattuada L; Linder KE; Swenson RE; Tweedle MF; Nunn AD
J Nucl Med; 2006 Jul; 47(7):1144-52. PubMed ID: 16818949
[TBL] [Abstract][Full Text] [Related]
3. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.
Maddalena ME; Fox J; Chen J; Feng W; Cagnolini A; Linder KE; Tweedle MF; Nunn AD; Lantry LE
J Nucl Med; 2009 Dec; 50(12):2017-24. PubMed ID: 19910427
[TBL] [Abstract][Full Text] [Related]
4. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.
Waser B; Eltschinger V; Linder K; Nunn A; Reubi JC
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):95-100. PubMed ID: 16909223
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
Dalm SU; Martens JW; Sieuwerts AM; van Deurzen CH; Koelewijn SJ; de Blois E; Maina T; Nock BA; Brunel L; Fehrentz JA; Martinez J; de Jong M; Melis M
J Nucl Med; 2015 May; 56(5):752-7. PubMed ID: 25791989
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
7. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
[TBL] [Abstract][Full Text] [Related]
8. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells.
Smith CJ; Gali H; Sieckman GL; Hayes DL; Owen NK; Mazuru DG; Volkert WA; Hoffman TJ
Nucl Med Biol; 2003 Feb; 30(2):101-9. PubMed ID: 12623108
[TBL] [Abstract][Full Text] [Related]
9. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
[TBL] [Abstract][Full Text] [Related]
10. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
Markwalder R; Reubi JC
Cancer Res; 1999 Mar; 59(5):1152-9. PubMed ID: 10070977
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC
Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites.
Linder KE; Metcalfe E; Arunachalam T; Chen J; Eaton SM; Feng W; Fan H; Raju N; Cagnolini A; Lantry LE; Nunn AD; Swenson RE
Bioconjug Chem; 2009 Jun; 20(6):1171-8. PubMed ID: 19480415
[TBL] [Abstract][Full Text] [Related]
13. Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers.
Sun B; Halmos G; Schally AV; Wang X; Martinez M
Prostate; 2000 Mar; 42(4):295-303. PubMed ID: 10679759
[TBL] [Abstract][Full Text] [Related]
14. Multimodality imaging and preclinical evaluation of 177Lu-AMBA for human prostate tumours in a murine model.
Liu IH; Chang CH; Ho CL; Chiu SP; Lee WC; Chang TJ; Chen LC; Wu YH; Chuang CH; Fu YK; Lee TW
Anticancer Res; 2010 Oct; 30(10):4039-48. PubMed ID: 21036718
[TBL] [Abstract][Full Text] [Related]
15. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast.
Gugger M; Reubi JC
Am J Pathol; 1999 Dec; 155(6):2067-76. PubMed ID: 10595936
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.
Yang YS; Zhang X; Xiong Z; Chen X
Nucl Med Biol; 2006 Apr; 33(3):371-80. PubMed ID: 16631086
[TBL] [Abstract][Full Text] [Related]
17. Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.
Lim JC; Cho EH; Kim JJ; Choi SM; Lee SY; Nam SS; Park UJ; Park SH
Nucl Med Biol; 2015 Mar; 42(3):234-41. PubMed ID: 25498002
[TBL] [Abstract][Full Text] [Related]
18. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T
J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957
[TBL] [Abstract][Full Text] [Related]
19. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
